Puerto Rico’s Pharma Bosses: “Focus Less on Tax Breaks, More on…
A group of industry experts who attended the Puerto Rico Manufacturers Association Convention this June 2019 have…
Patrick Burton |
Editor
Patrick is an editor at PharmaBoardroom, writing and editing stories on all things healthcare and the life sciences. The holder of a Master's Degree in International Relations, Patrick has contributed to over 30 country reports and is a fluent Mandarin speaker.
Articles: Patrick Burton
Chinese PD-1 Cancer Drugs: Global Competition for Big Pharma
PD-1 inhibitors have boosted survival rates for many cancer patients since their introduction in the US five years…
Swedish Pharmaceutical Exports Up 27% in Q1 2019
Sweden’s pharmaceutical exports shot up 27% in first quarter 2019, continuing an upward growth trend in an…
Chinese Government Outlines Healthcare Reform Priorities
More accessible and affordable healthcare for all: China’s government has outlined several proposals to…
Hansoh IPO Raises $1 Billion on Hong Kong Exchange
The company sold 551 million shares in the latest IPO on the Hong Kong Exchange and plans to invest half of its…
European MidPharmas: Focused and Resilient, yet Vulnerable
European MidPharmas – R&D based pharmaceutical companies with annual revenues of between EUR 50 million and 5…
New France Pharma Report June 2019 Out Now
The latest issue of Healthcare & Life Sciences Review France follows on from our March 2019 report and takes a…
Sweden’s Patient Register: In High Demand
Sweden’s comprehensive and high-quality system of electronic health records is increasingly in demand from…
Bio 2019 / Hong Kong Biotech IPOs Soaring in Line with China Pharma Market
With Hong Kong now established as the world’s second largest funding hub for biotech, at this week’s BIO 2019…
CEO Profile / Esteve: Out with the Old; In with the New
Esteve has long been a family-run business, though in early 2018 the Spanish champion decided to make a daring,…
China: Driving Big Pharma’s Sales Growth for the Long Term?
China is a hot topic in Big Pharma investor updates these days. The world’s second-largest pharmaceutical market…
Hong Kong Now the World’s Second Largest Funding Hub for Biotech
Hong Kong is now the world’s second largest funding hub for biotech according to Hong Kong Chief Executive…